ALTDORF, Switzerland—Datwyler is building a new plant in Delaware to manufacture elastomer components for injectable drug delivery systems, the Swiss company announced Oct. 4.
The company is investing $102 million in the plant, which it says will be “highly automated”.
Construction on the site is likely to start before the end of the year, with production scheduled for the first half of 2018. Once fully operational, the plant will create around 120 jobs.
The new production site will be designed in accordance with Datwyler's "FirstLine" standards, a manufacturing concept for high-quality elastomer components based on modern clean room technology, automated production cells and automated camera inspection.
Datwyler started its first plant in the U.S. in 1981 and supplies the health care and pharmaceutical markets throughout the country.